Insiders · Profile

Maizel Ari

Chief Commercial Officer at Axsome Therapeutics. Filing since 21 Jan 2026. CIK 0002042289

Company
Date
Role
Action
Shares
Amount
Of holding
22 Apr 2026
Chief Commercial Officer
Sold on a plan
7,500
$1.37M
100%
21 Jan 2026
Chief Commercial Officer
Sold on a plan
7,500
$1.38M
100%
2 decisions on file.